INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP), FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD, UNIVERSITE PARIS CITE FILES APPLICATION FOR "USE OF YKL-40 AS A BIOMARKER FOR ASSESSING FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE PATIENTS TREATED WITH ENDOVASCULAR THERAPY"

GENEVA, April 28 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (55 boulevard Diderot,75012 Paris), FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD (25-29 rue Manin75019 PARIS), UNIVERSITE PARIS CITE (85 Boulevard Saint-Germain,75006 Paris) filed a patent application (PCT/EP2024/079157) for "USE OF YKL-40 AS A BIOMARKER FOR ASSESSING FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE PATIENTS TREATED WITH ENDOVASCULAR THERAPY" on Oct 16, 2024. With publication no. WO/2025/083032, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC...